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Laboratory evidence suggests that vitamin A could have a protective effect on respiratory status in patients with cystic fibrosis (CF). This
study shows a significant correlation between serum vitamin A concentrations and every aspect of lung function tested in 38 patients with
stable CF. Serum vitamin D and vitamin E concentrations were also measured but did not show any significant correlations with lung
function.
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Recent laboratory evidence suggests that vitamin A could
have protective effects on the respiratory status of patients
with cystic fibrosis (CF). Thus, while elastinolytic protei-
nases (elastases) constitute a likely cause of tissue injury in
the lung in CF [1], vitamin A (retinoic acid, 100 nM), has
been shown to protect against elastase-induced lung damage
in bronchial epithelial cell lines in culture [2]. In addition,
retinoic acid (1 AM) has an anti-oxidant effect in the lung,
protecting against hyperoxia-mediated cell-cycle arrest of
lung alveolar epithelial cells by preserving late G1 cyclin
activities [3]. Inflammation has been shown to depress
serum vitamin A levels in CF [4], with recovery in serum
levels associated with the resolution of pulmonary exacer-
bations [4,5]. Serum vitamin A concentrations vary widely
in stable CF and are generally lower than the concentrations
observed in the general population [5]. The relationships
between serum vitamin A concentrations and respiratory
function in CF have not been studied.1569-1993/$ - see front matter D 2006 European Cystic Fibrosis Society. Publish
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were also measured and their relationships with lung
function were studied. Vitamin D is not known to have
any role on pulmonary inflammation, oxidative damage or
growth and development. Vitamin E is an anti-oxidant and
may have a role in the protection of lung tissue against
oxidative damage [6].2. Participants, methods and results
We studied 38 patients (mean age 15.3 years (range 6.1–
25.2 years), 20 males, mean FEV1 77% predicted (range
30–119% predicted)) with CF attending the Tayside clinic
for routine visits or annual reviews in the year 2002.
Inclusion criteria were age 6 years and older, performance of
reproducible spirometry and stable CF-related clinical status
at the time of the review. The mean height centile was
0.59 (range 4.53 to +1.71, standard deviation (SD)
1.18) and the mean weight centile was 0.68 (range 5.33
to +1.98, SD 1.39). The patients were on a mean dose of
6000 (range 0–17000) lipase units/kg/day. 3 patients were
pancreatic-sufficient. 5 had CF-related diabetes. 32 (82%)5 (2006) 129 – 131ed by Elsevier B.V. All rights reserved.
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nebulised DNase. All patients were prescribed regular
vitamin A, D and E supplementation as per the consensus
document for the UK (Nutritional management of Cystic
Fibrosis UK Cystic Fibrosis Trust Nutrition Working Group
(April 2002) on www.cftrust.org.uk). The study protocol was
approved by the Tayside Ethics Committee and informed
consent was obtained from subjects and/or their parent(s).
History-taking and clinical examination was performed
to confirm the absence of clinical exacerbation in order to
minimise the effect of acute inflammation on vitamin A
status. Although published evidence and consensus are
lacking on the criteria used to define an exacerbation, we
use criteria similar to those defined recently for a large,
prospective, multicentric study: relative decrease in percent
predicted forced expiratory volume in 1 second (FEV1),
increased cough frequency, new crackles and haemoptysis
[7]. Spirometry was performed in the clinic according to the
guidelines of the American Thoracic Society [8]. FEV1,
forced vital capacity (FVC) and peak expiratory flow (PEF)
were expressed as a percentage of predicted normal. Serum
vitamin A and E concentrations were measured by high
precision liquid chromatography [9] and serum vitamin DFig. 1. Significant ( p <0.05) correlations (Spearman’s) between (a) FEV1 and (b
correlation between (c) FEV1 and (d) FVC versus serum vitamin D concentrations
compared to serum vitamin D concentrations is observed for PEF.concentrations as 25-hydroxy-vitamin D using the Nicholls
Institute automated chemiluminescence immunoassay [10].
The data were non-normally distributed. The Spearman
rank correlation coefficient was used to study the associa-
tions between serum concentrations of vitamins A, D and E
and measures of lung function. Statistical significance was
assumed for P values <0.05 (2-tailed).
Serum vitamin A concentrations were variable and
significantly correlated with FEV1 (r =0.37, P=0.02),
FVC (r =0.39, P=0.02) and PEF (r=0.41, P=0.01) (Fig.
1). There were no significant correlations between serum
vitamin D concentrations and FEV1 (r =0.20, P=0.21),
FVC (r =0.20, P=0.22) and PEF (r=0.27, P=0.09) (Fig.
1). In addition, no significant correlations between vitamin
E concentrations and pulmonary function (FEV1 (r =0.08,
P=0.62), FVC (r =0.10, P=0.44) and PEF (r =0.10,
P=0.43)) were observed.3. Discussion
This is the first report of a consistent and specific
relationship between serum vitamin A concentrations and all) FVC versus serum vitamin A concentrations compared to the absence of
in patients with CF. A similar contrast in relationships with serum vitamin A
F.K. Aird et al. / Journal of Cystic Fibrosis 5 (2006) 129–131 131aspects of pulmonary function measured in the clinic setting
(FEV1, FVC, PEF) in children and young adults with
clinically stable CF. The observation was not replicated for
serum vitamin D and E concentrations. As observed by
others for CF, 40% of the serum vitamin A concentrations
were placed outside the reference range for the general
population (1.1–3.2 Amol/l).
A link between low dietary vitamin A intake and low
forced expiratory flow at 25–75% vital capacity has been
suggested in the general population of children, with the
authors proposing an anti-oxidant role for vitamin A in the
preservation of airway function [11]. Free neutrophil
elastase activity in induced sputum was also inversely
associated with FEV1 in 20 clinically stable children with
CF [12]. A potential mechanism is that relatively high
vitamin A concentrations in the airway fluid, resulting from
higher serum concentrations of vitamin A, inhibit elastase
and oxidant-induced damage to the pulmonary epithelium,
thus preserving pulmonary function in patients with CF.
Further studies are required to define this possible protective
pathway. The coefficient of determination (r2) values
calculated from the correlation coefficients suggest that
serum levels of vitamin A Fexplain_ 14–17% of the
observed variation in lung function, thus reflecting the
biological complexity underlying our observations.
In view of our findings, and other work relating vitamin
A status to respiratory health, it is important to study the
relationships between body vitamin A status, serum vitamin
A concentrations and airway surface fluid vitamin A
concentrations, in patients with CF and normal controls.
Other work has shown that a variable deficiency of acyl-
CoA:retinol acyltransferase, an enzyme facilitating vitamin
A absorption, occurs in CF and could be associated with
excessive faecal loss of vitamin A [13]. We speculate that
intrinsic differences in intestinal enzyme status could act as
determinants for the large differences in vitamin A status in
patients with CF.Acknowledgement
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